There
are an estimated 7 billion humans worldwide. That's 7,000,000,000, a huge
number. However, 7 billion pales in comparison to the estimated 10 to the power
31 viruses living alongside us - that's
10,000,000,000,000,000,000,000,000,000,000. Put another way, for every
predicted star in the universe there are 10 million viruses on Earth. Closer to
home, within each of us there are approximately 4 trillion viruses; yet for the
majority of our lives we will be healthy and free of viral disease. There are many
reasons for this, not least because most viruses have no interest in humans.
But another major factor is a set of cells and molecules to which we are deeply
indebted: these are the components that make up our immune system.
The
immune system can be broadly divided into two interlinked halves. There are the
front line, rapid responders comprising the innate immune system; cells and
molecules that are evolutionarily "designed" to react rapidly and
broadly, controlling invasion from any foreign organism. The second half is the
adaptive immune system. This has the big guns, taking longer to mobilize but
with the power to fully clear invading organisms following the initial
suppression from the innate system. Together these two halves co-ordinate a
response that effectively removes almost all infectious agents we encounter. Every
once in a while we will get briefly sick as the system kicks into full force,
but largely, we will never notice the silent protection it provides. The halves
are inseparable. However, without the rapid response of our innate system many
viruses and other pathogens would be able to gain a foothold and potentially
overwhelm us. Furthermore, the adaptive immune system cannot be triggered
unless the innate system warns it of an invasion, making the innate immune
system paramount for our survival.
Possibly
the most important players in the innate response to viral infection are a group
of proteins known as interferons (IFNs). Following an infection, IFNs trigger the
expression of 200-300 genes, producing effector proteins that function as part
of the innate immune response to block viral infection. It is known that these
IFN stimulated genes protect us, however, very little is known about the
function of individual proteins produced from these genes. In 2009 a major new component
in the IFN response was discovered that is now known as InterFeron-Induced
TransMembrane protein 3 (IFITM3). This protein was found through its ability to
protect cells from influenza virus infection. Influenza virus, or flu, annually
causes 3-5 million cases of clinical disease worldwide, and has the major
potential for pandemic spread. It was subsequently found that IFITM3 is present
in the cells of our lungs (the site of influenza infection) and that these
cells can be stimulated to express even more of this protective protein following
infection.
Most
importantly for the story of IFITM3, it was found not only to protect cells in
a laboratory, but also to protect us on a regular basis. Usually flu is a minor
illness, you simply get over it after a couple of weeks. However, certain people
can be hospitalized, or worse. In a study of patients hospitalized by
influenza, it has been found that a mutation in IFITM3 was over-represented. To
put it another way, it seems that people who carry a mutation in IFITM3 are at
an increased risk of severe flu infection.
What
makes IFITM3, and its close relatives IFITM1 and IFITM2, even more exciting is
that they don't just protect against influenza. At the time of writing, the
list of viruses the IFITMs protect against is in double figures
and includes some of the most notorious known to infect humans. Dengue virus, a
mosquito borne virus that threatens around 3 billion people, is sensitive to
IFITMs. Similarly, Ebola virus that can kill up to 90% of the people it infects
is restricted by the IFITMs. HIV may even be kept in check by the IFITM
proteins. This is to name but three. Obviously these viruses still cause
infections and still kill on a daily basis. However, without protection
provided by the IFITMs it is possible these viruses could be even greater
killers.
Currently,
we still do not completely understand how the IFITM proteins work. If this is fully
elucidated we may be able to produce drugs that mimic their protective
properties. Better yet, we may be able to regulate expression of the IFITMs or improve
on their function and provide even greater levels of protection. Imagine if we
could make a single drug that protected against infection by the four viruses
already mentioned and a whole host of others! This may be slightly blue-sky
thinking, but as someone at the start of a PhD in the field, that sky looks
pretty bright and appealing to me.
(NB. This article was entered into the Max Perutz Science Writing Competition run by the MRC by myself and is my own work in both cases)
(NB. This article was entered into the Max Perutz Science Writing Competition run by the MRC by myself and is my own work in both cases)